Condensed Consolidated Statements of Changes in Stockholders’ Equity - USD ($)	Total	Common Stock	Additional Paid-in-Capital	Retained Earnings	Accumulated Other Comprehensive Loss	Equity Attributable to Stockholders of the Company	Non-Controlling Interest
Beginning stock outstanding balance (in shares) at Dec. 31, 2018		27,612,597
Beginning balance at Dec. 31, 2018	$ 20,612,945	$ 27,613	$ 11,348,163	$ 10,617,253	$ (1,190,055)	$ 20,802,974	$ (190,029)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	1,860,003			1,858,587		1,858,587	1,416
Foreign currency translation	79,258				74,450	74,450	4,808
Ending stock outstanding balance (in shares) at Mar. 31, 2019		27,612,597
Ending balance at Mar. 31, 2019	22,552,206	$ 27,613	11,348,163	12,475,840	(1,115,605)	22,736,011	(183,805)
Beginning stock outstanding balance (in shares) at Dec. 31, 2019		27,612,597
Beginning balance at Dec. 31, 2019	34,893,210	$ 27,613	11,348,163	24,594,878	(908,764)	35,061,890	(168,680)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	1,611,354			1,611,354		1,611,354
Foreign currency translation	(760,055)				(755,522)	(755,522)	(4,533)
Purchase of minority interest	(762,479)		(935,692)			(935,692)	173,213
Ending stock outstanding balance (in shares) at Mar. 31, 2020		27,612,597
Ending balance at Mar. 31, 2020	$ 34,982,030	$ 27,613	$ 10,412,471	$ 26,206,232	$ (1,664,286)	$ 34,982,030	$ 0